Ravensburg, Germany, May 8, 2009 / b3c newswire / - West (NYSE: WST), the world’s premier manufacturer of components and systems for injectable drug delivery, and Vetter, a worldwide leading independent specialist in the contract manufacturing of prefilled application systems, have introduced a ready-to-use, WFI prefilled syringe for reconstituting lyophilized drug products.
“The Vetter/West WFI syringe combines the best of pharmaceutical components in a drug administration system that we believe customers will embrace,” said Mike Schaefers, Vice President, Marketing, Europe, West. “This system can be applied to our customers’ high-value pharmaceutical and biopharmaceutical drug products.”
“This system unites two of the world’s leaders in drug administration systems and pharmaceutical processing,” said Oskar Gold, Vice President, Key Account Management, Vetter. “We are pleased that we can offer customers a world-class prefilled syringe system.”
The syringe features a plunger with West’s FluroTec® barrier film and Vetter’s V-OVS® tamper-evident closure, which includes a West tip cap. The film, developed by West’s partner, Daikyo Seiko, Ltd., provides an effective barrier against organic and inorganic extractables, which helps maintain the purity of the diluent.
The V-OVS® closure system is designed to give a prefilled syringe system effective protection features. It consists of a tip cap, a Vetter Luer Lock and a tamper-evident seal. The components are pre-assembled as a single part, which is mounted on the syringe barrel with a Luer-cone and Luer-groove. The integrity of the syringe system is maintained if the seal has not been broken. The syringes are available with fill volumes between 0.5mL and 3.0mL. The glass syringe barrels are treated with baked silicone for lubricity and are 100 percent visually inspected to provide highest quality levels.
Customers will have packaging options, including individual blister packaging.
Vetter fills and terminally sterilizes the syringe at its facility in Langenargen, Germany. The syringes are supplied with regulatory documentation to meet requirements of markets in Europe, Japan, North America and numerous other countries.
West is a global manufacturer of components and systems for injectable drug delivery, including stoppers and seals for vials, and closures and disposable components used in syringe, IV and blood collection systems. The Company also provides products with application to the personal care, food and beverage markets. Headquartered in Lionville, Pennsylvania, West supports its partners and customers from 50 locations throughout North America, South America, Europe, Mexico, Japan, Asia and Australia. For more information, visit West at www.westpharma.com.
Vetter is an independent international specialist in the production of aseptically pre-filled injection systems, cartridges and vials. Based in Ravensburg, Germany, Vetter also produces its own injection systems, such as the Vetter Lyo-Ject® dual-chamber syringe. With about 1,900 employees worldwide, Vetter holds about 140 patents and has longstanding experience in handling client products and processes approved by the FDA, EMEA and other authorities.
FluroTec® is a registered trademark of West Pharmaceutical Services, Inc. in the United States and other jurisdictions.
FluroTec technology is licensed from Daikyo Seiko, Ltd.
Vetter and V-OVS® are registered trademarks of Vetter Pharma-Fertigung GmbH& Co.KG in Germany, the United States and other jurisdictions.
MixJect® is a registered trademark of Medimop Medical Projects Inc.
For more information contact
Vetter Pharma International GmbH
phone: +49-(0)751-3700 - 0
fax: +49-(0)751-3700 - 40 00